Methotrexate
Product manufactured by Par Pharmaceutical, Inc.
Indications and Purposes
| 1 Indications And Usage Methotrexate Tablets Is A Dihydrofolate Reductase Inhibitor Indicated For The: Treatment Of Adults And Pediatric Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen ( 1.1 ) Treatment Of Adults With Mycosis Fungoides ( 1.1 ) Treatment Of Adults With Relapsed Or Refractory Non-Hodgkin Lymphoma As Part Of A Metronomic Combination Regimen ( 1.1 ) Treatment Of Adults With Rheumatoid Arthritis ( 1.2 ) Treatment Of Pediatric Patients With Polyarticular Juvenile Idiopathic Arthritis (Pjia) ( 1.3 ) Treatment Of Adults With Severe Psoriasis ( 1.4 ) 1.1 Neoplastic Diseases Methotrexate Tablets Is Indicated For The: Treatment Of Adults And Pediatric Patients With Acute Lymphoblastic Leukemia (All) As Part Of A Combination Chemotherapy Maintenance Regimen Treatment Of Adults With Mycosis Fungoides (Cutaneous T-Cell Lymphoma) As A Single Agent Or As Part Of A Combination Chemotherapy Regimen. Treatment Of Adults With Relapsed Or Refractory Non-Hodgkin Lymphomas As Part Of A Metronomic Combination Chemotherapy Regimen 1.2 Rheumatoid Arthritis Methotrexate Tablets Is Indicated For The Treatment Of Adults With Rheumatoid Arthritis. 1.3 Polyarticular Juvenile Idiopathic Arthritis Methotrexate Tablets Is Indicated For The Treatment Of Pediatric Patients With Polyarticular Juvenile Idiopathic Arthritis (Pjia). 1.4 Psoriasis Methotrexate Tablets Is Indicated For The Treatment Of Adults With Severe Psoriasis. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Methotrexate Sodium |
|
ZINC1529323 |